{"id":"https://openalex.org/W2906880846","doi":"https://doi.org/10.22159/ajpcr.2018.v11s4.31738","title":"EVALUATING THE COST-EFFECTIVENESS OF DIFFERENT GROUPS OF HYPERTENSION THERAPY: A PHARMACOECONOMIC STUDY","display_name":"EVALUATING THE COST-EFFECTIVENESS OF DIFFERENT GROUPS OF HYPERTENSION THERAPY: A PHARMACOECONOMIC STUDY","publication_year":2018,"publication_date":"2018-12-28","ids":{"openalex":"https://openalex.org/W2906880846","doi":"https://doi.org/10.22159/ajpcr.2018.v11s4.31738","mag":"2906880846"},"language":"en","primary_location":{"id":"doi:10.22159/ajpcr.2018.v11s4.31738","doi":"https://doi.org/10.22159/ajpcr.2018.v11s4.31738","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ajpcr.2018.v11s4.31738","pdf_url":"https://innovareacademics.in/journals/index.php/ajpcr/article/download/31738/16651","source":{"id":"https://openalex.org/S2764968390","display_name":"Asian Journal of Pharmaceutical and Clinical Research","issn_l":"0974-2441","issn":["0974-2441","2455-3891"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-40"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Journal of Pharmaceutical and Clinical Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://innovareacademics.in/journals/index.php/ajpcr/article/download/31738/16651","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036824606","display_name":"Roobena Parveen A","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138876546","display_name":"Vels University","ror":"https://ror.org/00tscx035","country_code":"IN","type":"education","lineage":["https://openalex.org/I138876546"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Roobena Parveen A","raw_affiliation_strings":["Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels University, Pallavaram, Chennai - 600 043, Tamil Nadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels University, Pallavaram, Chennai - 600 043, Tamil Nadu, India","institution_ids":["https://openalex.org/I138876546"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043959708","display_name":"Muddala Vara Prasanna Rao","orcid":"https://orcid.org/0000-0002-9056-121X","observed_orcids":["https://orcid.org/0000-0002-9056-121X"]},"institutions":[{"id":"https://openalex.org/I138876546","display_name":"Vels University","ror":"https://ror.org/00tscx035","country_code":"IN","type":"education","lineage":["https://openalex.org/I138876546"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Vara Prasanna Rao M","raw_affiliation_strings":["Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels University, Pallavaram, Chennai - 600 043, Tamil Nadu, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels University, Pallavaram, Chennai - 600 043, Tamil Nadu, India","institution_ids":["https://openalex.org/I138876546"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I138876546"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"11","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.7792999744415283,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.7792999744415283,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.21389999985694885,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10924","display_name":"Cardiovascular Health and Disease Prevention","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.9039999842643738},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.8980000019073486},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9959999918937683},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9290000200271606},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9850000143051147},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":1.0},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.9710000157356262},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness-ratio","display_name":"incremental cost-effectiveness ratio","score":0.8560000061988831},{"id":"https://openalex.org/keywords/pharmacoeconomics","display_name":"pharmacoeconomics","score":0.6430000066757202}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8661470413208008},{"id":"https://openalex.org/C2910553456","wikidata":"https://www.wikidata.org/wiki/Q285044","display_name":"Angiotensin Receptor Blockers","level":4,"score":0.665037989616394},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.6423814296722412},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.575704038143158},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4179893732070923},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.3081349730491638},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.22159/ajpcr.2018.v11s4.31738","doi":"https://doi.org/10.22159/ajpcr.2018.v11s4.31738","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ajpcr.2018.v11s4.31738","pdf_url":"https://innovareacademics.in/journals/index.php/ajpcr/article/download/31738/16651","source":{"id":"https://openalex.org/S2764968390","display_name":"Asian Journal of Pharmaceutical and Clinical Research","issn_l":"0974-2441","issn":["0974-2441","2455-3891"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-40"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Journal of Pharmaceutical and Clinical Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.22159/ajpcr.2018.v11s4.31738","doi":"https://doi.org/10.22159/ajpcr.2018.v11s4.31738","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ajpcr.2018.v11s4.31738","pdf_url":"https://innovareacademics.in/journals/index.php/ajpcr/article/download/31738/16651","source":{"id":"https://openalex.org/S2764968390","display_name":"Asian Journal of Pharmaceutical and Clinical Research","issn_l":"0974-2441","issn":["0974-2441","2455-3891"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-40"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Journal of Pharmaceutical and Clinical Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2906880846.pdf","grobid_xml":"https://content.openalex.org/works/W2906880846.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W1994222210","https://openalex.org/W2009165423","https://openalex.org/W2056359618","https://openalex.org/W2103920520","https://openalex.org/W2159507083","https://openalex.org/W2530345137","https://openalex.org/W2959634101"],"related_works":["https://openalex.org/W4393388898","https://openalex.org/W2770718216","https://openalex.org/W392055470","https://openalex.org/W3176867479","https://openalex.org/W2625277142","https://openalex.org/W2142524033","https://openalex.org/W2739587158","https://openalex.org/W2391713654","https://openalex.org/W26318131","https://openalex.org/W4389057512"],"abstract_inverted_index":{"Objective:":[0],"The":[1],"study":[2,32],"objective":[3],"is":[4,54,89],"to":[5,17,47,56,68],"evaluate":[6],"among":[7],"the":[8,21,60,93,160],"different":[9],"groups":[10],"of":[11,24,62,120,131,163],"antihypertensive":[12,40],"for":[13,84,96,102],"their":[14],"cost-effectiveness":[15,58,87],"and":[16,28,80,100,124,144,157,167],"provide":[18],"information":[19],"about":[20],"effective":[22,141,150,161],"management":[23,61,162],"hypertensives":[25,164],"both":[26,165],"clinically":[27,166],"economically.":[29,168],"Methods:":[30],"This":[31],"involves":[33],"81":[34],"patients":[35],"aged":[36],"18\u201380":[37],"years":[38],"on":[39,92],"treatment":[41],"who":[42],"were":[43],"enrolled":[44],"from":[45],"December":[46],"May":[48],"with":[49,71],"daily":[50],"dose":[51],"calculation.":[52],"It":[53],"performed":[55],"analyze":[57],"in":[59,142,151],"clinical":[63,78],"condition.":[64],"Data":[65],"collection":[66],"form":[67],"be":[69],"entered":[70],"age,":[72],"sex,":[73],"food":[74],"habits,":[75],"occupational":[76],"status,":[77],"data,":[79],"drugs":[81],"was":[82],"used":[83],"treatment.":[85],"Incremental":[86],"ratio":[88],"calculated":[90],"based":[91],"incremental":[94],"cost":[95,101,140,149],"\u201cper":[97,103],"mmHg\u201d":[98],"reduction":[99,119,130],"patient\u201d":[104],"reaching":[105],"target":[106],"blood":[107],"pressure":[108],"(BP).":[109],"Result:":[110],"Angiotensin":[111],"receptor":[112],"blockers":[113,147],"(ARBs)":[114],"show":[115,127,159],"a":[116],"significant":[117],"average":[118,129],"systolic":[121],"BP":[122,133],"(SBP)":[123],"beta-blockers":[125],"(BBs)":[126],"an":[128],"diastolic":[132],"(DBP).":[134],"Angiotensin-converting":[135],"enzyme":[136],"inhibitors":[137],"(ACEIs)":[138],"are":[139,148],"SBP":[143],"calcium":[145],"channel":[146],"maintaining":[152],"DBP.":[153],"Conclusion:":[154],"ARBs,":[155],"BBs,":[156],"ACEIs":[158]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2019-01-11T00:00:00"}